Balance about balANZ.
作者信息
Blake Peter G
机构信息
Division of Nephrology, University of Western Ontario, London, Ontario, Canada.
出版信息
Perit Dial Int. 2012 Sep-Oct;32(5):493-6. doi: 10.3747/pdi.2012.00225.
Abstract
摘要
相似文献
1
Balance about balANZ.关于平衡（balANZ）的平衡。 （注：这里的“balANZ”看起来像是个特定名称或术语，直接保留英文，整体翻译可能不太符合常规语境，推测原文可能有误，正常应该是“Balance about balance”之类更通顺的表述，但按照要求逐字翻译是这样。）
Perit Dial Int. 2012 Sep-Oct;32(5):493-6. doi: 10.3747/pdi.2012.00225.
2
The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial.生物相容型与标准腹膜透析液对腹膜炎微生物学、治疗和结局影响的比较：balANZ 试验。
Perit Dial Int. 2012 Sep-Oct;32(5):497-506. doi: 10.3747/pdi.2012.00052.
3
What is the role of automated peritoneal dialysis and continuous flow peritoneal dialysis?自动腹膜透析和持续循环腹膜透析的作用是什么？
Contrib Nephrol. 2003(140):264-71. doi: 10.1159/000071399.
4
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.生物相容性与标准液对腹膜透析结果的影响。
J Am Soc Nephrol. 2012 Jun;23(6):1097-107. doi: 10.1681/ASN.2011121201. Epub 2012 Mar 22.
5
Alterations of dialysate markers in chronic peritoneal dialysis patients treated with the new less bioincompatible bicarbonate solutions.使用新型低生物不相容性碳酸氢盐溶液治疗的慢性腹膜透析患者透析液标志物的变化。
Perit Dial Int. 2011 Mar-Apr;31(2):196-9. doi: 10.3747/pdi.2009.00139.
6
Normal peritoneum after nine years of peritoneal dialysis with biocompatible dialysate: a case report.使用生物相容性透析液进行九年腹膜透析后的正常腹膜：一例报告
Perit Dial Int. 2013 Nov-Dec;33(6):712-4. doi: 10.3747/pdi.2012.00306.
7
The balANZ study--strengthening the evidence for neutral-pH solutions low in glucose degradation products.平衡研究——强化关于低葡萄糖降解产物的中性pH值溶液的证据
Perit Dial Int. 2012 Sep-Oct;32(5):489-92. doi: 10.3747/pdi.2012.00204.
8
Ten years after MIDAS: icodextrin lights and shadows.MIDAS十年后：艾考糊精的利弊
Contrib Nephrol. 2003(140):76-81. doi: 10.1159/000071426.
9
Economic evaluation of neutral-pH, low-glucose degradation product peritoneal dialysis solutions compared with standard solutions: a secondary analysis of the balANZ Trial.中性 pH、低葡萄糖降解产物腹膜透析液与标准液的经济学评价：BALANZ 试验的二次分析。
Am J Kidney Dis. 2015 May;65(5):773-9. doi: 10.1053/j.ajkd.2014.12.017. Epub 2015 Mar 4.
10
Multidirectional approach to study peritoneal dialysis fluid biocompatibility in a chronic peritoneal dialysis model in the rat.在大鼠慢性腹膜透析模型中采用多方向方法研究腹膜透析液的生物相容性。
Nephrol Dial Transplant. 2001 Mar;16(3):655-6. doi: 10.1093/ndt/16.3.655.
引用本文的文献
1
Effect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis.中性pH、低葡萄糖降解产物腹膜透析液对残余肾功能、尿量及超滤的影响：一项系统评价和Meta分析
Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1380-8. doi: 10.2215/CJN.05410514. Epub 2015 Jun 5.
本文引用的文献
1
The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial.生物相容型与标准腹膜透析液对腹膜炎微生物学、治疗和结局影响的比较：balANZ 试验。
Perit Dial Int. 2012 Sep-Oct;32(5):497-506. doi: 10.3747/pdi.2012.00052.
2
The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial.低糖降解产物、中性 pH 值与标准腹膜透析液对腹膜功能影响的研究：balANZ 试验。
Nephrol Dial Transplant. 2012 Dec;27(12):4445-53. doi: 10.1093/ndt/gfs314. Epub 2012 Aug 1.
3
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.生物相容性与标准液对腹膜透析结果的影响。
J Am Soc Nephrol. 2012 Jun;23(6):1097-107. doi: 10.1681/ASN.2011121201. Epub 2012 Mar 22.
4
A new neutral-pH low-GDP peritoneal dialysis fluid.一种新的中性 pH 值、低 GDP 的腹膜透析液。
Perit Dial Int. 2012 Jul-Aug;32(4):444-52. doi: 10.3747/pdi.2011.00072. Epub 2012 Mar 1.
5
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique survival.将患者随机分配到生物相容或常规腹膜透析溶液的长期随访结果显示，腹膜炎或技术生存率无差异。
Kidney Int. 2011 Nov;80(9):986-991. doi: 10.1038/ki.2011.244. Epub 2011 Aug 3.
6
Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study.低 GDP 液（甘丙肽三联）可减缓 PD 患者残余肾功能下降：一项前瞻性随机研究。
Nephrol Dial Transplant. 2010 Jul;25(7):2288-96. doi: 10.1093/ndt/gfq087. Epub 2010 Mar 1.
7
Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solution.一种纯碳酸氢盐缓冲腹膜透析液的生物相容性和耐受性。
Perit Dial Int. 2009 Nov-Dec;29(6):647-55.
8
Preserving residual renal function in peritoneal dialysis: volume or biocompatibility?维持腹膜透析患者的残余肾功能：容量控制还是生物相容性？
Nephrol Dial Transplant. 2009 Sep;24(9):2620-2. doi: 10.1093/ndt/gfp313. Epub 2009 Jun 23.
9
Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.生物相容性腹膜透析液对新确诊的持续性非卧床腹膜透析患者残余肾功能的保护作用：一项为期1年的研究。
Nephrol Dial Transplant. 2009 Sep;24(9):2899-908. doi: 10.1093/ndt/gfp054. Epub 2009 Mar 3.
10
Short-term effects of bicarbonate/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study.碳酸氢盐/乳酸盐缓冲液与传统乳酸盐缓冲液透析液对腹膜超滤的短期影响：一项比较性交叉研究
Nephrol Dial Transplant. 2009 May;24(5):1617-25. doi: 10.1093/ndt/gfn673. Epub 2008 Dec 9.
Zotero 插件